NASDAQ
Ascendis Pharma A/S (ASND) has a price/sales ratio of 15.90x as of Friday, May 22, 2026. This represents a 93.66% decrease compared to its 12-month average of 250.82x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.